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Abstract
Background: China has been one of the countries with high prevalence of chronic hepatitis B virus (HBV) and 
hepatitis C virus (HCV) liver disease. And lichen planus is an extrahepatic manifestation of patients with chronic 
HCV infection. This case-control study was conducted to investigate the relationship between oral lichen planus 
(OLP) and HBV/HCV infection in China. 
Material and Methods: A total of 776 patients, including 150 patients with OLP (Group OLP), 429 inpatients from 
the Trauma Ward of Oral and Maxillofacial Surgery Department (Group A), 110 patients with other oral mucosal 
diseases, but without a reported association with HCV infection (Group B) and 87 patients with oral lichenoid le-
sion (Group OLL), were compared with their seroprevalence of anti-HCV antibody (HCVAb), hepatitis B surface 
antigen (HBsAg) and the parameters of liver functions. Moreover, the clinical characteristics of OLP were also 
observed, such as gender, age, chief complaint, course of the disease, clinical type, sites involved and so on. 
Results: The positive rates of HCVAb and HBsAg in OLP patients were 0.7% and 4%, respectively. Neither HCV-
Ab nor HBsAg was associated with OLP as demonstrated by both the univariate and the multivariate analyses. 
The clinical features and liver functions of OLP patients with negative or positive HBsAg were nearly the same. 
Conclusions: Our findings verify that there is no association between OLP and hepatitis and there is no need to run 
a screening test for HCV or HBV in OLP patients in China.
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Introduction 
Oral Lichen planus (OLP) is a chronic inflammatory 
mucocutaneous disorder, mainly affecting the middle 
aged female patients. It is estimated to occur in 0.2-2.3% 
of the general population and it represents about 0.6% 
of all diseases that the dentists frequently meet (1). The 
clinical characteristics of OLP are white striae which 
often differentiate into reticular, papular, plaque like, 
bullous, atrophic, and erosive types. Oral lichenoid le-
sion (OLL), a disease entity that resembles OLP clinical-
ly and pathologically, can be caused by dental materials, 
drugs or chronic graft versus host diseases (cGvHD). 
In some instances, OLP and OLL are indistinguishable, 
only that OLL has a definitive causative agent. Patients 
with both disease entities can experience no symptoms 
or non-specific symptoms of burning, itching, or pain-
ful sensations. The characteristics of persistence and li-
ability for malignant transformation remarkably dama-
ge the patients’ quality of life.    
HCV, a single-stranded ribonucleic acid (RNA) virus, 
was first identified in 1989 (2). Approximately 40-74% of 
HCV infected patients have extrahepatic manifestations 
(3), such as mixed cryoglobulinemia, Non-Hodgkin’s 
lymphoma, porphyria cutanea tarda, lichen planus, sicca 
syndrome or thyroid dysfunctions. It was first reported to 
be associated with OLP in 1991 (4) and since then many 
researches demonstrate a positive relationship between 
OLP and HCV infection and even some recommend the 
screening tests for HCV in OLP patients (5-7). OLP in 
certain populations can be used as a marker of HCV in-
fection in asymptomatic patients, thus helping the diag-
nosis, early treatment, and possibly a better prognosis. 
However, if this is not a true association, the routine 
testing of OLP patients for HCV may result in the un-
necessary use of medical resources, with increased costs 
and other harmful effects such as the increased anxiety 
among those tested. So it is very important to identify the 
association between these two disease categories. 
Hepatitis B virus (HBV) is a type of hepadnavirus. Few 
researches have been done to investigate the associa-
tion between OLP and HBV infection (6,8-10). Only one 
study confirmed a weak association between OLP and 
hepatitis B surface antigen (HBsAg) (9). China has one 
of the highest HBV carriers prevalence in the world 
(11). Still little has been known about the relationship 
between OLP and HBV infection. 
Therefore, in this study, we aimed to investigate the re-
lationship between OLP and HCV and HBV infection 
in China.
 
Material and Methods
- Subjects 
Approval from the biomedical institutional review 
board of Peking University School of Stomatology 
was received before starting the study (PKUSSIRB-
201413033). Data were extracted from the patients’ re-
cords in Peking University School of Stomatology from 
January 2011 to August 2014. The serums of all the par-
ticipants were collected by the Department of Clinical 
Laboratory of Peking University School of Stomatol-
ogy. HCV antibody (HCVAb), HBsAg and liver func-
tions were then measured. 
The prevalence of hepatitis C in China is estimated to be 
1% (12), and we intended to detect a six-fold increase in 
the prevalence of hepatitis C among OLP patients with a 
significance level of 5% (13). The power of the test was 
set at 80% (β=0.2). As OLP is not a very common disea-
se, we chose a ratio of 2:1 between controls and cases. 
Based on these assumptions and the equation for estima-
ting sample size, the final sample size of OLP patients 
was 150, in consideration of 10% loss in follow up rate. 
In the current study, one experimental group and three 
different control groups were enrolled. In total, 776 pa-
tients were included. Of which, there were 150 consecu-
tive patients with OLP (Group OLP, the experimental 
group), 429 inpatients from the Trauma Ward of Oral 
and Maxillofacial Surgery Department (Group A, the 
first control group), 110 patients with other oral mucosal 
diseases, but without a reported association with HCV 
infection (Group B, the second control group) and 87 
patients with oral lichenoid lesion (Group OLL, the 
third  control group). All the patients of Group OLP, 
Group B and Group OLL were outpatients from the De-
partment of Oral Medicine, Peking University School 
of Stomatology. 
The diagnostic criteria for OLP and OLL were based on 
the clinical and pathological diagnosis (14,15). Patients 
in Group A were all the inpatients with maxillofacial 
trauma from January 2011 to August 2014 and aged 
over 18 years. Patients in Group B were outpatients 
with other mucosal diseases including, but not limited 
to burning mouth syndrome, recurrent aphthous ulcer, 
chronic cheilitis and geographic glossitis. 
Demographic data and information concerning the 
clinical features of OLP, such as the chief complaint, 
course of the disease, clinical type of the lesions, sites 
of involvement and skin lesion, were obtained through 
the clinical records of all participants.  
- Laboratory tests
All the blood samples were collected after an overnight 
fasting period. HBsAg and HCVAb were detected by an 
automated chemiluminescence immunoassay (CLIA) 
analyzer (the Architect i2000 system). Liver functions, 
such as serum level of alanine aminotransferase (ALT), 
aspartate aminotransferase (AST), total protein (TP), 
albumin (Alb), alkaline phosphatase (ALP), and lactate 
dehydrogenase (LDH), were assayed by an automatic 
biochemistry analyzer (H7180, Hitachi). Hemoglobin 
concentration (Hb) and platelet count (PLT) were mea-
sured by the automated hematology analyzer (XS-1000i, 
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Sysmex). To confirm the authenticity and reliability, all 
the data were stored as electrical information by two 
different researchers.
- Statistical analysis
The collected data were analyzed using SPSS-15.0 soft-
ware. The differences of the positive rates of HCVAb 
and HBsAg between the experimental group and the 
control groups were evaluated by the χ2 test and Fisher 
exact test (HCVAb between Group OLP and Group B). 
Parameters of the liver functions were presented as the 
mean and standard deviation (SD), the differences of 
which between experimental group and control groups 
were compared using the independent t test. Then the 
parameters of the liver functions were recorded into bi-
nary variables, which were normal and abnormal (cod-
ed as 0 and 1), according to the normal references range. 
The latter were used for the later statistical analysis. The 
binary logistic regression analysis was used to measure 
the association between OLP status and the presence of 
HCVAb and / or HBsAg as well as the liver functions. 
All statistical tests were 2-sided, and a value of P≤0.05 
was considered to be statistically significant. 
Results
The demographic data of the study groups were depic-
ted in table 1. There were significant differences regar-
ding the ages between Group OLP and the other three 
groups. Furthermore, there were more male patients in 
Group OLP than in Group OLL (P=0.01). 
- Clinical characteristics of OLP patients
Half of the 150 OLP patients came to our department 
presenting with white lesions (82,54.7%) and the rest 
complained of an irritating pain (37, 24.7%), roughness 
(4, 2.7%), and other sufferings (22, 14.7%). The shortest 
duration of the disease was one week while the longest 
was 20 years with the mean duration of (15.37±34.57) 
months. The clinical types of the lesions included re-
ticular (61, 40.7%), atrophic (46, 30.7%) and erosive (43, 
28.7%) varieties. The most commonly involved sites (as 
shown in figure 1) were the buccal mucosa (136, 90.7%), 
the dorsal tongue (47, 31.3%), the vestibular groove (44, 
29.3%), the floor of the mouth and ventral tongue (39, 
26%), the gingiva (28, 18.7%), the lip (21, 14%), and the 
palate (2, 1.3%) in a descending order with 12 patients 
involved with the complexion. 
Variables 
Group 
OLP 
N=150 
Group 
A 
N=429 
Group 
B 
N=110 
Group 
OLL 
N=87 
P1 
value 
P2 
value 
P3 
value 
Age 
(mean, SD) 
43.15 
11.56 
39.26 
14.41 
48.65 
14.31 
51.45 
10.25 0.001 0.001 0.000 
Gender 
Male(%) 
Female(%) 
 
61 (40.7) 
89 (59.3) 
 
193 (45.0) 
236 (55.0) 
 
38 (34.5) 
72 (65.5) 
 
21 (24.1) 
66 (75.9) 
 
0.359 
 
0.315 
 
0.010 
HCVAb 
Positive(%) 
Negative(%) 
 
1 (0.7) 
149 (99.3) 
 
4 (0.9) 
425 (99.1) 
 
1 (0.9) 
109 (99.1) 
 
3 (3.4) 
84 (96.6) 
 
1 
 
1 0.280 
HBsAg 
Positive(%) 
Negative(%) 
 
6 (4) 
144 (96) 
 
23 (5.4) 
406 (94.6) 
 
2 (1.8) 
108 (98.2) 
 
5 (5.7) 
82 (94.3) 
0.511 0.520 0.501 
Hb (g/L) 
(Mean, SD) 
144.75 
16.04 
131.52 
19.58 
141.39 
13.99 
147.26 
25.06 0.000 0.083 0.352 
PLT (/L) 
(Mean, SD) 
243.14 
57.99 
238.79 
71.63 
242.27 
64.35 
219.53 
56.09 0.503 0.910 0.003 
ALT (U/L) 
(Mean, SD) 
24.77 
25.33 
22.03 
41.79 
22.69 
19.86 
25.02 
15.92 0.451 0.476 0.932 
AST (U/L) 
(Mean, SD) 
25.09 
13.02 
27.77 
114.39 
23.69 
9.47 
25.26 
10.89 0.777 0.340 0.919 
TP (g/L) 
(Mean, SD) 
74.35 
3.83 
67.12 
5.86 
74.11 
4.51 
75.18 
3.85 0.000 0.646 0.110 
Alb (g/L) 
(Mean, SD) 
48.45 
2.88 
43.91 
4.14 
46.50 
3.77 
48.75 
3.03 0.000 0.000 0.458 
ALP (U/L) 
(Mean, SD) 
67.95 
17.82 
61.20 
25.19 
74.34 
32.20 
75.13 
26.44 0.003 0.045 0.026 
LDH (U/L) 
(Mean, SD) 
178.03 
30.94 
173.2 
147.51 
179.35 
33.08 
178.34 
27.49 0.698 0.750 0.940 
 
Table 1. The differences between Group OLP and control groups by univariate analysis.
SD: standard deviation  
P1 value: Group OLP versus Group A
P2 value: Group OLP versus Group B
P3 value: Group OLP versus Group OLL
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- The association between OLP and HCVAb, HBsAg and 
liver functions
The positive rates of HCVAb were highest in Group OLL 
(3/87, 3.4%), identical in Group A and Group B (4/429, 
0.9% and 1/110, 0.9%) and lowest in Group OLP (1/150, 
0.7%). But none of these differences were significant 
(Table 1).   The positive rates of HBsAg in Group OLL, 
Group A, Group OLP and Group B were 5.7%, 5.4%, 4% 
and 1.8%, respectively. However, the differences among 
these groups were not significant (Table 1). The parame-
ters of liver functions were presented as mean±SD (Table 
1). All the values were within normal range. However, 
Hb, TP, Alb, and ALP in Group OLP were higher than 
in Group A. There was one inpatient, positive for HB-
sAg, with dramatical high values of ALT (778U/L), AST 
(2383U/L) and LDH (3103U/L) in Group A, so the SD of 
these three parameters was remarkably high. If the evalu-
ation was made without including these data, the results 
were the same except that the SD of ALT, AST and LDH 
in Group A would decrease a lot. 
In order to exclude the confounding effects of age, gen-
der and other unknown factors, we utilized the binary 
logistic regression to adjust the multiple factors that 
were associated with OLP. In all the regression models, 
the ALT1 (the recoded binary variable of ALT), HCVAb 
and HBsAg were entered. And the other factors, added 
in the model, were those with significant differences 
in the univariate analysis (Table 2). After adjusting the 
Fig. 1.  Sites involved in OLP patients. 
The sites that involved in OLP patients in decending orders. BM, buccal mucosa; DT, dorsum 
of tongue; VG, vestibular groove; FM&VT, floor of mouth and ventral tongue; G, gingiva; L, 
lip; P, palate.
Variable OR 95%CI P-value Groups 
age 
Hb1 
TP1 
1.019 
5.571 
4.118 
1.005; 1.033 
2.191; 14.169 
1.045; 16.223 
0.006 
＜0.001 
0.043 
aGroup OLP vs Group A 
bage, Hb1, ALT1, TP1, 
ALP1, HBsAg, HCVAb 
age 
 
 
0.966 
 
 
0.946; 0.985 
 
 
0.001 
 
 
Group OLP vs Group B 
age, ALT1, TP1, ALP1, 
HBsAg, HCVAb 
age 
gender 
ALT1 
0.930 
0.483 
0.367 
0.904; 0.957 
0.250; 0.931 
0.142; 0.948 
＜0.001 
0.030 
0.038 
Group OLP vs Group 
OLL age, gender, PLT1, 
ALT1, ALP1, HBsAg, 
HCVAb 
 
Table 2. Binary logistic regression for the association between OLP and parameters of 
liver function, HBsAg, and HCVAb. 
Hb1: Hb<120 (in male) and Hb<115 (in female) coded as 1, the rest as 2.
TP1: TP<80 (in male), TP<85 (in female) coded as 1, the rest as 2.
ALT1: ALT<40 coded as 1, the rest as 2.
a: binary logistic regression model (back: wald)
b: the variables that included when establishing the binary logistic regression model.
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multiple factors, the binary logistic regression showed 
there was no association between OLP and HCVAb or 
HBsAg (Table 2), the same as the univariate analysis 
demonstrated above (Table 1). Although we found that 
Hb and TP were higher in Group OLP than in Group 
A (Table 1), both the mean values were within normal 
range. When compared to Group B, only the age was 
found significantly different. The OLP patients were 
male and younger when compared to OLL patients. And 
among the 87 patients, none had skin lesions, whereas the 
12 OLP patients had a skin involvement. Interestingly, 
the OLL patients had the highest positive rates of HCVAb 
and HBsAg. However, the differences were not signifi-
cant by both the univariate and multivariate analyses.
- Clinical features of OLP associated with hepatitis
All the four patients with white both clinical lesions and 
positive HCVAb (1 with OLP and 3 with OLL) were 
females and aged over 50 years. Two patients suffered 
from an irritating pain while the other two complained 
of white lesions. The course of the disease varied from 
one month to sixty months. All the lesions were bilateral 
without skin involvement. As there was only one OLP 
patient with positive HCVAb, it was not possible to com-
pare the differences in regard to the clinical features be-
tween positive and negative HCVAb in Group OLP.    
Five male and one female OLP were patients positive for 
HBsAg (Table 3). Their mean age was (46.67 ±9.09) years 
(range, 35-54 years). Half patients (n=3) complained of 
white striae lesions and the remaining suffered from an 
irritating pain. The lesion types included reticular (n=2), 
atrophic (n=2) and erosive (n=2) types. The course of the 
disease varied from 1 month to 12 months with a mean 
duration of (5.5±5.1) months. There were no differenc-
es between HBsAg negative and HBsAg positive OLP 
patients in relation to the clinical characteristics (age, 
gender, chief complaints, course of the disease, type of 
lesions and skin lesions) and the parameters of liver func-
tions by both univariate (Table 3) and multivariate analy-
ses, except for the serum level of albumin.
Variables  
HBsAg 
positive 
(n=6) 
HBsAg 
negative 
(n=144) 
P value 
Age (year) 46.67
9.09 43.01 11.66 0.449 
Course of disease 5.50 5.13 15.78 35.22 0.477 
Gender 
Male (%) 
Female (%) 
 
5 (83.3) 
1 (16.7) 
 
56 (38.9) 
88 (61.1) 
 
0.081 
Chief complaint 
Symptomatic (%) 
Asymptomatic (%) 
 
3 (50.0) 
3 (50.0) 
 
65 (45.1) 
79 (54.9) 
 
1 
Clnical types 
Erosive (%) 
Atrophic (%) 
Reticular (%) 
 
2 (33.3) 
2 (33.3) 
2 (33.3) 
 
41 (28.5) 
44 (30.5) 
59 (41.0) 
0.713 
Skin lesion 
No (%) 
Yes (%) 
 
6 (100) 
0 (0) 
 
132 (91.7) 
12 (8.3) 
1 
Hb (g/L) 
(Mean, SD) 
152.67 
14.65 
144.42 
16.05 0.218 
PLT (/L) 
(Mean, SD) 
202.17 
33.48 
244.86 
58.24 0.077 
ALT (U/L) 
(Mean, SD) 
44.50 
48.58 
23.94 
23.85 0.349 
AST (U/L) 
(Mean, SD) 
37.33 
30.65 
24.58 
11.70 0.356 
TP (g/L) 
(Mean, SD) 
73.00 
5.33 
74.41 
3.77 0.379 
Alb (g/L) 
(Mean, SD) 
45.67 
2.50 
48.57 
2.84 0.015 
ALP (U/L) 
(Mean, SD) 
73.33 
20.68 
67.73 
17.74 0.452 
LDH (U/L) 
(Mean, SD) 
190.33 
15.41 
177.51 
31.35 0.322 
 
Table 3. The differences between positive and negative HBsAg patients in 
Group OLP.
SD: standard deviation. 
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Discussion
The probable relationship between OLP and liver disea-
se has been discovered since 1978 (16). After HCV was 
indentified in 1989, several studies have found the co-
existence of HCV and OLP. Then in 1991 it was first 
reported to be associated with OLP (4). A large scale 
study showed that the prevalence of HCV in OLP pa-
tients was three times higher than that of the control 
group (1.9% and 0.4%, respectively, P<0.001) and rec-
ommended a screening test of HCV in OLP patients (6). 
In 2004, Lodi et al. carried out a multi-center study to 
investigate the association between OLP and HCV in-
fection (13) and found that the positive rate of HCVAb 
in OLP group was seven times as high as that of the 
control group. In their systemic review, which included 
24 case-control studies, the overall odds ratio (OR) was 
nearly five (OLP group compared to the control group) 
and the results were different when compared different 
age groups, control groups (17), different countries or 
regions and different study designs (13,18). 
Despite the enormous papers published in the literature, 
the relationship between HCV and OLP is still highly 
controversial. Pilli et al. found HCV-specific T-cell 
responses at the site of the lesions of HCV associated 
OLP, strongly suggesting a role for HCV-specific T-cell 
responses in the pathogenesis of OLP associated with 
HCV infection (19). Whereas, Femiano et al. did not 
find the viral genome in oral epithelium of the patients 
with both OLP and HCV (20). And still it is very im-
portant to find out the true relationship between OLP 
and HCV. If there is no association between these two 
diseases, we could avoid the additional psychological 
pressure and the unnecessary medical resources spent 
on OLP patients.
In China, few researches (21) have been done in the 
recent 10 years which demonstrated no relationship 
between these two disorders. However, in that study, 
the control group was confusing and needed to be im-
proved. Therefore, in our study we chose three control 
groups from the same hospital of OLP patients. The es-
timated HCV prevalence in Chinese population was 1% 
(12), almost identical to those of the two control groups 
(Group A and Group B, both were 0.9%). Moreover, 
these two control groups enabled us to identify the preva-
lence of chronic HCV/HBV infection in the population 
referred to the same hospital (22). Although these four 
study groups were not completely matched as regard 
age and gender, the binary logistic regression was used 
to adjust the multi-factors that associated with OLP. The 
strict inclusion and exclusion criteria were used to select 
the OLP patients. And there were large proportions of 
OLL patients among the clinical white striae patients. 
Accidentally, the positive rate of HCVAb was found to 
be highest in Group OLL. The main reason might be 
that the mean age of Group OLL was highest among the 
study groups (as shown in table 1) and the positive rate 
of HCVAb increases with age (23) as dose the prevalen-
ce of OLP. Another reason may be that the histopatho-
logical results of the oral white striae lesions associated 
with HCV infection were more likely to be lichenoid 
reaction (24). But more researches are still needed to 
verify this possibility. The seroprevalence of HCVAb 
was not associated with OLP as testified by both the 
univariate analysis and the binary logistic regression 
models. Reviewing the literatures for the relationship 
between OLP and HCV in the recent 10 years, only 
three case-control studies showed positive relationship 
between these two disorders (Table 4). And the criteria 
of these studies were not clear. The other seven studies 
revealed no association between OLP and HCV regard-
less of the prevalence of HCV in the general popula-
tions. Compared to our research, many other reports 
showed OLP might not be relevant to HCV in certain 
regions. Therefore, there is no need to run a screening 
test of HCV in OLP patients in China.
Several studies investigated the association between 
OLP and HBV infection and demonstrated no relation-
ship between these two diseases (6,8). Whereas, in 1990, 
 
Author 
 
Year 
 
Country 
Prevalence of  
HCV 
 
Age 
Gender 
(female/male) 
 
Criteriaa 
 
Conclusionb 
Bratic (28) 2004 Serbia 1.76/100000 49.7 33/15 No No 
Campisi (23) 2004 Italy 12.6%-26.0% 54.3 531/328 Yes No 
Giuliani (24) 2007 Italy NS 62.9 54/25 Yes No 
Birkenfeld (6) 2010 Israel 0.4% 53.7 927/630 No Yes 
Lin (7) 2010 Taiwan 4.3% 56 79/25 No Yes 
Zhou (21) 2010 China 1% NS 168/64 No No 
Petti (29) 2011 Iran NS (low) 44.1 371/103 Yes No 
Jayavelu (30) 2012 India 0.9%-1.2% NS 15/15 No No 
Nagao (5) 2012 Japan NS (high) 68.1 45/15 No Yes 
Patil (26) 2012 India NS  43.5 84/46 Yes No 
 
Table 4. Case-control studies in regard to the association of OLP and HCV in recent 10 years.
NS: not specified
aCriteria: both clinical and histopathological confirmed of OLP and excluded drug lichenoid reactions 
or dental materials lichenoid reactions.
bConclusion: positive association between oral lichen planus and hepatitis C virus infection.
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another study found a weak association between HBV 
infection and OLP (9) when the association between 
OLP and HCV infection was not discovered and the 
author suggested that there might be an indirect rela-
tion between  non-A non-B hepatitis and LP. In the cur-
rent study, the positive rates of HBsAg in Group OLL, 
Group OLP and Group A were higher than in Group B. 
But none of these differences were significant. So the 
epidemiological investigation established no relation-
ship between OLP and HBsAg.  
The relationship between the parameters of liver func-
tions and OLP varies in few studies. ALT (9,25) and 
AST (8,9,25) were reported to be higher in OLP pa-
tients. In addition, TP, Alb and ALP showed no dif-
ferences (25). Patil et al. found no differences of ALT, 
AST and ALP between OLP patients and the controls 
(26). In the current study, the multivariate analysis 
demonstrated that Hb and TP were found to be higher 
when compared to Group A. ALT was lower than that 
of Group OLL. AST, Alb, ALP and LDH showed no 
differences between Group OLP and the three control 
groups. And all these values were within normal range. 
Together with the results of HCVAb and HBsAg, there 
is no association of hepatitis with OLP, evaluated by the 
epidemiological study.    
The reported main clinical type of OLP patients, most 
commonly associated with HCV infection, was the atro-
phic-erosive type (8,9), and the lesions mainly involved 
the buccal mucosa (8). Whereas, in our study, the OLP 
patients with HCV infection presented with reticular le-
sions, which is in concordance to what Romero observed 
(27). Few researches investigated the clinical features of 
OLP patients with positive HBsAg. While the present 
study demonstrated that they were almost identical to 
those of OLP patients with negative HBsAg. 
In conclusion, OLP might not be an extra-hepatic mani-
festation of HCV infection in Chinese patients. There 
is no need to run the screening test of HCVAb and HB-
sAg for OLP patients in China and further fundamental 
studies are needed to shed the light on the pathogenesis 
of OLP involved with HCV. 
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